<ѻý>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetesѻý> Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<ѻý>Restrictions on Mifepristone a Barrier to Miscarriage Care, Surveys Showѻý> Over a third of respondents do not prescribe the drug for early pregnancy loss, despite efficacy May 10, 2022
<ѻý>Early Alzheimer's Test Gets FDA Nodѻý> First in vitro diagnostic to detect amyloid in early disease setting May 05, 2022
<ѻý>Two New Regimens Win FDA Approval for H. Pylori Infectionѻý> Dual and triple vonoprazan-based treatments offer physicians another set of options May 04, 2022
<ѻý>How Far Should the Menthol Ban Go?ѻý> It's time to ban menthol in cigarettes -- but not necessarily in all tobacco products May 02, 2022
<ѻý>FDA OKs New Nonstimulant Option for Adult ADHDѻý> New selective norepinephrine reuptake inhibitor is no longer just for kids May 02, 2022
<ѻý>FDA Proposes Ban on Menthol Cigarettesѻý> "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
<ѻý>FDA Approves First Drug for Recurrent Yeast Infectionsѻý> Vivjoa indicated for infertile or postmenopausal women Apr 28, 2022
<ѻý>FDA Issues Warning on Prenatal Genetic Testsѻý> Relying on results could lead to inappropriate medical decisions, agency warns Apr 19, 2022
<ѻý>First Topical Therapy for Facial Angiofibroma Nabs FDA Approvalѻý> New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
<ѻý>ALS Drug Needs More Evidence, FDA Advisors Sayѻý> But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
<ѻý>Another Oral Testosterone Undecanoate OK'd for Hypogonadismѻý> FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
<ѻý>Novel Fixed-Dose Immunotherapy Combo Wins FDA Approvalѻý> Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
<ѻý>Medicare Claws Back Money for Dubious Birth-Tissue Stem Cell Shotsѻý> Government seeks to recoup more than 2 years of payments for unproven treatments Mar 16, 2022
<ѻý>Meet the Primary Care Doc Who Wants the World to Go Back to Normalѻý> Lucy McBride, MD, has become a loud, controversial voice in the debate on COVID precautions Mar 15, 2022
<ѻý>First Generic OK'd for Popular Asthma, COPD Inhalerѻý> FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
<ѻý>FDA Warns on Using Surgical Device for Aesthetic Skin Proceduresѻý> Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
<ѻý>FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancerѻý> Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
<ѻý>FDA Begins Releasing Pfizer COVID Vax Documentsѻý> Court-ordered release runs risk of "cherry picking and taking things out of context" Mar 07, 2022
<ѻý>Dr. Bronner's Offering Its Workers Psychedelic Therapy Coverageѻý> Soap company to cover ketamine-assisted therapy for employees with new industry nonprofit Mar 01, 2022
<ѻý>Thumbs Down for IV Tramadol, FDA Advisers Sayѻý> Delayed onset of pain relief remains a concern Feb 16, 2022
<ѻý>FDA OKs 180-Day Implantable Continuous Glucose Monitorѻý> Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
<ѻý>FDA Warns of Strangulation Risk for Kids on Feeding Tubesѻý> Two toddlers died after being found with enteral feeding systems' tubing around their necks Feb 09, 2022
<ѻý>FDA Concerned About Safety of Lymphoma Drugѻý> Hint of excess mortality in trial of umbralisib/ublituximab prompts public notice Feb 03, 2022
<ѻý>FDA Approves First Generic of Restasis for Dry Eyeѻý> A new option for those affected by keratoconjunctivitis sicca Feb 02, 2022
<ѻý>Another COVID Vaccine Garners Full FDA Approvalѻý> Moderna's Spikevax approved for adults ages 18 and up Jan 31, 2022
<ѻý>Are We Equipped to Care for People With Intellectual, Developmental Disabilities?ѻý> Low accreditation standards are contributing to health disparities Jan 20, 2022
<ѻý>FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitisѻý> Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
<ѻý>Growing Controversy Over 'Skinny' Labeling for Generic Drugsѻý> What's at stake in legal battles over patent-avoiding approval pathway for generics Jan 17, 2022
<ѻý>(When) to Boost or Not to Boost, That Is the Questionѻý> Countless complex questions remain Jan 13, 2022
<ѻý>Why Are Physicians Silent About Outrageous Drug Prices?ѻý> Milton Packer wonders why physicians are struggling to get their priorities straight Jan 12, 2022
<ѻý>Nose or Throat: What’s Best for a COVID Test?ѻý> Early data support saliva testing, but it might be too early to tell Jan 06, 2022
<ѻý>FDA OKs Endogenous Cushing's Syndrome Treatmentѻý> Recorlev reduced and normalized cortisol levels in clinical studies Jan 04, 2022
<ѻý>Alzheimer's Drugs Race to FDAѻý> After aducanumab, drug companies pivot to use the accelerated approval pathway Jan 01, 2022
<ѻý>What Happened to the Novavax Vaccine?ѻý> As mRNA vaccines saturate the U.S. market, is there room for another? Jan 01, 2022
<ѻý>'Pending Wave' of Nurse Substance Use Problems?ѻý> Signs point to deepening issue with alcohol, drugs as nurses battle through the pandemic Dec 30, 2021
<ѻý>Doctor Submits Fluvoxamine EUA Application to FDAѻý> Group of physician-scientists believes data support authorization for treating COVID-19 Dec 29, 2021
<ѻý>IL-13 Inhibitor Approved for Adults With Atopic Dermatitisѻý> Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
<ѻý>FDA Approves First Long-Acting Injectable to Prevent HIV Infectionѻý> Apretude is administered every 2 months versus a daily pill Dec 21, 2021
<ѻý>Novel Myasthenia Gravis Treatment Wins FDA Nodѻý> Efgartigimod is the first approved FcRn blocker Dec 20, 2021